Further studies revealed that, upon targeting the mitochondria of tumor cells, Mito-ICT-4 downregulated SIRT3 protein expression, disrupted intracellular redox homeostasis, and markedly increased mitochondrial ROS levels. This evidence concerns the gene SIRT3 and neoplasm.